Zhang Yu

639 Zhizaoju Road, P.R. China
Shanghai, 200011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Single-cell sequencing of facial adipose tissue unveils FKBP5 as a therapeutic target for facial infiltrating lipomatosis.

Single-cell sequencing of facial adipose tissue unveils FKBP5 as a therapeutic target for facial infiltrating lipomatosis.

Journal: Stem cell research & therapy

Published: May 09, 2024

Concurrent PIK3CA and IDH1 variants in facial infiltrating lipomatosis with intracranial lesions.

Concurrent PIK3CA and IDH1 variants in facial infiltrating lipomatosis with intracranial lesions.

Journal: Genes & diseases

Published: November 06, 2023

Distribution of problematic localized facial infantile haemangiomas and their response to propranolol: a retrospective cohort study.

Distribution of problematic localized facial infantile haemangiomas and their response to propranolol: a retrospective cohort study.

Journal: Clinical and experimental dermatology

Published: February 10, 2023

CD146+ mural cells from infantile hemangioma display proangiogenic ability and adipogenesis potential in vitro and in xenograft models.

CD146+ mural cells from infantile hemangioma display proangiogenic ability and adipogenesis potential in vitro and in xenograft models.

Journal: Frontiers in oncology

Published: October 07, 2022

Apelin Receptor Can Act as a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma.

Apelin Receptor Can Act as a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma.

Journal: The Journal of investigative dermatology

Published: November 29, 2021

The effect of 0.5% topical timolol cream on regression of superficial infantile haemangioma in the involuting phase: a prospective, randomized, self-controlled study.

The effect of 0.5% topical timolol cream on regression of superficial infantile haemangioma in the involuting phase: a prospective, randomized, self-controlled study.

Journal: European journal of dermatology : EJD

Published: November 13, 2020

Topical rapamycin in superficial lymphatic malformation: Microcystic lymphatic malformation or verrucous venous malformation?

Topical rapamycin in superficial lymphatic malformation: Microcystic lymphatic malformation or verrucous venous malformation?

Journal: Journal of the American Academy of Dermatology

Published: January 07, 2019

Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.

Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.

Journal: The Journal of dermatology

Published: November 05, 2018

The Imbalance of Lymphocyte Subsets and Cytokines: Potential Immunologic Insights Into the Pathogenesis of Chronic Dacryocystitis.

The Imbalance of Lymphocyte Subsets and Cytokines: Potential Immunologic Insights Into the Pathogenesis of Chronic Dacryocystitis.

Journal: Investigative ophthalmology & visual science

Published: April 04, 2018

Enhanced bioactivity and osteoinductivity of carboxymethyl chitosan/nanohydroxyapatite/graphene oxide nanocomposites.

Enhanced bioactivity and osteoinductivity of carboxymethyl chitosan/nanohydroxyapatite/graphene oxide nanocomposites.

Journal: RSC advances

Published: January 13, 2018

Infantile hemangioma: factors causing recurrence after propranolol treatment.

Infantile hemangioma: factors causing recurrence after propranolol treatment.

Journal: Pediatric research

Published: February 11, 2017

When to stop propranolol for infantile hemangioma.

When to stop propranolol for infantile hemangioma.

Journal: Scientific reports

Published: October 13, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026